JPH02184618A - Ir reflective transparent cosmetic composition - Google Patents
Ir reflective transparent cosmetic compositionInfo
- Publication number
- JPH02184618A JPH02184618A JP63332710A JP33271088A JPH02184618A JP H02184618 A JPH02184618 A JP H02184618A JP 63332710 A JP63332710 A JP 63332710A JP 33271088 A JP33271088 A JP 33271088A JP H02184618 A JPH02184618 A JP H02184618A
- Authority
- JP
- Japan
- Prior art keywords
- particle size
- composition
- composition according
- infrared
- infrared reflective
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 64
- 239000002537 cosmetic Substances 0.000 title claims abstract description 20
- 239000002245 particle Substances 0.000 claims abstract description 24
- 239000000126 substance Substances 0.000 claims abstract description 23
- 239000011521 glass Substances 0.000 claims abstract description 11
- 229940073609 bismuth oxychloride Drugs 0.000 claims abstract description 9
- 239000000919 ceramic Substances 0.000 claims abstract description 9
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 claims abstract description 9
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000010419 fine particle Substances 0.000 claims abstract description 8
- 235000019271 petrolatum Nutrition 0.000 claims abstract description 7
- 229910052726 zirconium Inorganic materials 0.000 claims abstract description 6
- 239000006185 dispersion Substances 0.000 claims abstract description 5
- 230000005540 biological transmission Effects 0.000 claims abstract 3
- 239000003921 oil Substances 0.000 claims description 20
- 239000000839 emulsion Substances 0.000 claims description 19
- 239000004166 Lanolin Substances 0.000 claims description 17
- 235000019388 lanolin Nutrition 0.000 claims description 17
- 229940039717 lanolin Drugs 0.000 claims description 17
- -1 dianisoylmethane Chemical compound 0.000 claims description 16
- 230000005855 radiation Effects 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 11
- 239000000194 fatty acid Substances 0.000 claims description 11
- 229930195729 fatty acid Natural products 0.000 claims description 11
- 239000006071 cream Substances 0.000 claims description 10
- 150000003839 salts Chemical class 0.000 claims description 10
- 239000003795 chemical substances by application Substances 0.000 claims description 9
- 150000002191 fatty alcohols Chemical class 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 8
- 239000004005 microsphere Substances 0.000 claims description 8
- 239000001993 wax Substances 0.000 claims description 8
- 239000003995 emulsifying agent Substances 0.000 claims description 7
- 238000012216 screening Methods 0.000 claims description 7
- 239000007762 w/o emulsion Substances 0.000 claims description 7
- 150000004665 fatty acids Chemical class 0.000 claims description 6
- 239000003205 fragrance Substances 0.000 claims description 6
- 239000000499 gel Substances 0.000 claims description 5
- 239000003755 preservative agent Substances 0.000 claims description 5
- 238000002834 transmittance Methods 0.000 claims description 5
- UZKWTJUDCOPSNM-UHFFFAOYSA-N 1-ethenoxybutane Chemical compound CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 claims description 4
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical group NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 claims description 4
- 241000206761 Bacillariophyta Species 0.000 claims description 4
- 150000002148 esters Chemical class 0.000 claims description 4
- 125000000649 benzylidene group Chemical group [H]C(=[*])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims description 3
- 229920001577 copolymer Polymers 0.000 claims description 3
- 239000003380 propellant Substances 0.000 claims description 3
- 239000003352 sequestering agent Substances 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- 239000002562 thickening agent Substances 0.000 claims description 3
- 229960004050 aminobenzoic acid Drugs 0.000 claims description 2
- 239000003963 antioxidant agent Substances 0.000 claims description 2
- 239000012965 benzophenone Substances 0.000 claims description 2
- 239000012964 benzotriazole Substances 0.000 claims description 2
- 239000003086 colorant Substances 0.000 claims description 2
- 229920001519 homopolymer Polymers 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 239000002674 ointment Substances 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- 239000000725 suspension Substances 0.000 claims description 2
- 239000003981 vehicle Substances 0.000 claims description 2
- 239000011782 vitamin Substances 0.000 claims description 2
- 229940088594 vitamin Drugs 0.000 claims description 2
- 235000013343 vitamin Nutrition 0.000 claims description 2
- 229930003231 vitamin Natural products 0.000 claims description 2
- ZYEMGPIYFIJGTP-UHFFFAOYSA-N O-methyleugenol Chemical compound COC1=CC=C(CC=C)C=C1OC ZYEMGPIYFIJGTP-UHFFFAOYSA-N 0.000 claims 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 claims 2
- CWLGEPSKQDNHIO-JOBJLJCHSA-N (e)-n-[(e)-benzylideneamino]-1-phenylmethanimine Chemical compound C=1C=CC=CC=1/C=N/N=C/C1=CC=CC=C1 CWLGEPSKQDNHIO-JOBJLJCHSA-N 0.000 claims 1
- LALVCWMSKLEQMK-UHFFFAOYSA-N 1-phenyl-3-(4-propan-2-ylphenyl)propane-1,3-dione Chemical compound C1=CC(C(C)C)=CC=C1C(=O)CC(=O)C1=CC=CC=C1 LALVCWMSKLEQMK-UHFFFAOYSA-N 0.000 claims 1
- HMKKFLSUPRUBOO-IUPFWZBJSA-N 3,4-dihydroxy-5-[3,4,5-tris[[(z)-octadec-9-enoyl]oxy]benzoyl]oxybenzoic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC1=C(OC(=O)CCCCCCC\C=C/CCCCCCCC)C(OC(=O)CCCCCCC\C=C/CCCCCCCC)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(O)=O)O)=C1 HMKKFLSUPRUBOO-IUPFWZBJSA-N 0.000 claims 1
- WDMFHQNUSVLQMS-UHFFFAOYSA-N 5-(3,3-dimethyl-2-bicyclo[2.2.1]heptanylidene)pent-3-en-2-one Chemical compound C1CC2C(C)(C)C(=CC=CC(=O)C)C1C2 WDMFHQNUSVLQMS-UHFFFAOYSA-N 0.000 claims 1
- RDBLNMQDEWOUIB-UHFFFAOYSA-N 5-methyl-2-phenyl-1,3-benzoxazole Chemical compound N=1C2=CC(C)=CC=C2OC=1C1=CC=CC=C1 RDBLNMQDEWOUIB-UHFFFAOYSA-N 0.000 claims 1
- OMFXVFTZEKFJBZ-UHFFFAOYSA-N Corticosterone Natural products O=C1CCC2(C)C3C(O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 OMFXVFTZEKFJBZ-UHFFFAOYSA-N 0.000 claims 1
- 239000002518 antifoaming agent Substances 0.000 claims 1
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 claims 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 claims 1
- 229940114081 cinnamate Drugs 0.000 claims 1
- 150000001851 cinnamic acid derivatives Chemical class 0.000 claims 1
- 230000001054 cortical effect Effects 0.000 claims 1
- OMFXVFTZEKFJBZ-HJTSIMOOSA-N corticosterone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@H](CC4)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OMFXVFTZEKFJBZ-HJTSIMOOSA-N 0.000 claims 1
- MCPKSFINULVDNX-UHFFFAOYSA-N drometrizole Chemical compound CC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 MCPKSFINULVDNX-UHFFFAOYSA-N 0.000 claims 1
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical compound N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 claims 1
- HPMLGOFBKNGJAM-ONEGZZNKSA-N ethyl (e)-3-(1h-imidazol-5-yl)prop-2-enoate Chemical compound CCOC(=O)\C=C\C1=CN=CN1 HPMLGOFBKNGJAM-ONEGZZNKSA-N 0.000 claims 1
- TUKWPCXMNZAXLO-UHFFFAOYSA-N ethyl 2-nonylsulfanyl-4-oxo-1h-pyrimidine-6-carboxylate Chemical compound CCCCCCCCCSC1=NC(=O)C=C(C(=O)OCC)N1 TUKWPCXMNZAXLO-UHFFFAOYSA-N 0.000 claims 1
- 239000003906 humectant Substances 0.000 claims 1
- 229940116837 methyleugenol Drugs 0.000 claims 1
- PRHTXAOWJQTLBO-UHFFFAOYSA-N methyleugenol Natural products COC1=CC=C(C(C)=C)C=C1OC PRHTXAOWJQTLBO-UHFFFAOYSA-N 0.000 claims 1
- 239000011859 microparticle Substances 0.000 claims 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 claims 1
- 229960001860 salicylate Drugs 0.000 claims 1
- BBHVQBQNEHFBIO-UHFFFAOYSA-M sodium;2-(3,4-dimethoxyphenyl)-2-oxoacetate Chemical compound [Na+].COC1=CC=C(C(=O)C([O-])=O)C=C1OC BBHVQBQNEHFBIO-UHFFFAOYSA-M 0.000 claims 1
- 239000004094 surface-active agent Substances 0.000 claims 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M trans-cinnamate Chemical compound [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 claims 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 claims 1
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 claims 1
- 150000003722 vitamin derivatives Chemical class 0.000 claims 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract description 6
- 239000005909 Kieselgur Substances 0.000 abstract 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 23
- 235000019198 oils Nutrition 0.000 description 15
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 12
- 235000011187 glycerol Nutrition 0.000 description 9
- 210000003491 skin Anatomy 0.000 description 9
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 8
- 239000012071 phase Substances 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 239000002253 acid Substances 0.000 description 7
- 239000003925 fat Substances 0.000 description 6
- 229940057995 liquid paraffin Drugs 0.000 description 6
- 229940114926 stearate Drugs 0.000 description 6
- 206010015150 Erythema Diseases 0.000 description 5
- 235000013871 bee wax Nutrition 0.000 description 5
- 239000012166 beeswax Substances 0.000 description 5
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- 239000008346 aqueous phase Substances 0.000 description 4
- 231100000321 erythema Toxicity 0.000 description 4
- 235000019359 magnesium stearate Nutrition 0.000 description 4
- 229940114930 potassium stearate Drugs 0.000 description 4
- ANBFRLKBEIFNQU-UHFFFAOYSA-M potassium;octadecanoate Chemical compound [K+].CCCCCCCCCCCCCCCCCC([O-])=O ANBFRLKBEIFNQU-UHFFFAOYSA-M 0.000 description 4
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 3
- 230000009931 harmful effect Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- BBMCTIGTTCKYKF-UHFFFAOYSA-N n-Heptanol Natural products CCCCCCCO BBMCTIGTTCKYKF-UHFFFAOYSA-N 0.000 description 3
- 229920005862 polyol Polymers 0.000 description 3
- 150000003077 polyols Chemical class 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- ZQBAKBUEJOMQEX-UHFFFAOYSA-N salicylic acid phenyl ester Natural products OC1=CC=CC=C1C(=O)OC1=CC=CC=C1 ZQBAKBUEJOMQEX-UHFFFAOYSA-N 0.000 description 3
- 229920002545 silicone oil Polymers 0.000 description 3
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 2
- GAZOQRUEIUBTNF-UHFFFAOYSA-N 1-[4-(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]-3-[[[4-(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]carbamoylamino]methyl]urea Chemical class N1C(=O)NC(=O)C1(CO)NC(=O)NCNC(=O)NC1(CO)NC(=O)NC1=O GAZOQRUEIUBTNF-UHFFFAOYSA-N 0.000 description 2
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 2
- LSPHULWDVZXLIL-UHFFFAOYSA-N Camphoric acid Natural products CC1(C)C(C(O)=O)CCC1(C)C(O)=O LSPHULWDVZXLIL-UHFFFAOYSA-N 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 206010042496 Sunburn Diseases 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- LSPHULWDVZXLIL-QUBYGPBYSA-N camphoric acid Chemical compound CC1(C)[C@H](C(O)=O)CC[C@]1(C)C(O)=O LSPHULWDVZXLIL-QUBYGPBYSA-N 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 239000004200 microcrystalline wax Substances 0.000 description 2
- 235000019808 microcrystalline wax Nutrition 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- SSZBUIDZHHWXNJ-UHFFFAOYSA-N palmityl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCC SSZBUIDZHHWXNJ-UHFFFAOYSA-N 0.000 description 2
- 229960000969 phenyl salicylate Drugs 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000004584 polyacrylic acid Substances 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 150000004671 saturated fatty acids Chemical class 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000001540 sodium lactate Substances 0.000 description 2
- 235000011088 sodium lactate Nutrition 0.000 description 2
- 229940005581 sodium lactate Drugs 0.000 description 2
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000003672 ureas Chemical class 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 1
- KIHBGTRZFAVZRV-UHFFFAOYSA-N 2-Hydroxyoctadecanoic acid Natural products CCCCCCCCCCCCCCCCC(O)C(O)=O KIHBGTRZFAVZRV-UHFFFAOYSA-N 0.000 description 1
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 1
- PJTNSWOJMXNNFG-UHFFFAOYSA-N 8-methylnonyl 2-hydroxybenzoate Chemical compound CC(C)CCCCCCCOC(=O)C1=CC=CC=C1O PJTNSWOJMXNNFG-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-M 9-cis,12-cis-Octadecadienoate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC([O-])=O OYHQOLUKZRVURQ-HZJYTTRNSA-M 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- KHBQMWCZKVMBLN-UHFFFAOYSA-N Benzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC=C1 KHBQMWCZKVMBLN-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241001246270 Calophyllum Species 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 101000779425 Pisum sativum Albumin-1 A Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 244000297179 Syringa vulgaris Species 0.000 description 1
- 235000004338 Syringa vulgaris Nutrition 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 235000010724 Wisteria floribunda Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 150000008366 benzophenones Chemical class 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N cinnamic acid Chemical class OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- KCDAMWRCUXGACP-DHZHZOJOSA-N ethyl (e)-2-cyano-3-phenylprop-2-enoate Chemical compound CCOC(=O)C(\C#N)=C\C1=CC=CC=C1 KCDAMWRCUXGACP-DHZHZOJOSA-N 0.000 description 1
- XCRHYAQWBYDRGV-UHFFFAOYSA-N ethyl 3-(4-propan-2-ylphenyl)prop-2-enoate Chemical compound CCOC(=O)C=CC1=CC=C(C(C)C)C=C1 XCRHYAQWBYDRGV-UHFFFAOYSA-N 0.000 description 1
- 229940068171 ethyl hexyl salicylate Drugs 0.000 description 1
- 229940067592 ethyl palmitate Drugs 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- QAKXLTNAJLFSQC-UHFFFAOYSA-N hexadecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC QAKXLTNAJLFSQC-UHFFFAOYSA-N 0.000 description 1
- 229960004881 homosalate Drugs 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 231100000405 induce cancer Toxicity 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940075495 isopropyl palmitate Drugs 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 229940049918 linoleate Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- SJOXEWUZWQYCGL-DVOMOZLQSA-N menthyl salicylate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)C1=CC=CC=C1O SJOXEWUZWQYCGL-DVOMOZLQSA-N 0.000 description 1
- 229960004665 menthyl salicylate Drugs 0.000 description 1
- JZMJDSHXVKJFKW-UHFFFAOYSA-M methyl sulfate(1-) Chemical compound COS([O-])(=O)=O JZMJDSHXVKJFKW-UHFFFAOYSA-M 0.000 description 1
- ZANFQAKBYANGPR-UHFFFAOYSA-M methyl sulfate;trimethyl-[4-[(4,7,7-trimethyl-3-oxo-2-bicyclo[2.2.1]heptanylidene)methyl]phenyl]azanium Chemical compound COS([O-])(=O)=O.CC1(C)C2CCC1(C)C(=O)C2=CC1=CC=C([N+](C)(C)C)C=C1 ZANFQAKBYANGPR-UHFFFAOYSA-M 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 229940105132 myristate Drugs 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical compound C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 231100000589 photocarcinogenesis Toxicity 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- IWHVCHNCTHGORM-UHDJGPCESA-M potassium;(e)-3-phenylprop-2-enoate Chemical compound [K+].[O-]C(=O)\C=C\C1=CC=CC=C1 IWHVCHNCTHGORM-UHDJGPCESA-M 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 239000011253 protective coating Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- ZCTQGTTXIYCGGC-UHFFFAOYSA-N salicylic acid benzyl ester Natural products OC1=CC=CC=C1C(=O)OCC1=CC=CC=C1 ZCTQGTTXIYCGGC-UHFFFAOYSA-N 0.000 description 1
- 150000003902 salicylic acid esters Chemical class 0.000 description 1
- SJOXEWUZWQYCGL-UHFFFAOYSA-N salicylic acid menthyl ester Natural products CC(C)C1CCC(C)CC1OC(=O)C1=CC=CC=C1O SJOXEWUZWQYCGL-UHFFFAOYSA-N 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 150000003900 succinic acid esters Chemical class 0.000 description 1
- CXVGEDCSTKKODG-UHFFFAOYSA-N sulisobenzone Chemical compound C1=C(S(O)(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 CXVGEDCSTKKODG-UHFFFAOYSA-N 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- QGISLNJSJIGSLZ-UHFFFAOYSA-N trimethyl-[4-[(4,7,7-trimethyl-3-oxo-2-bicyclo[2.2.1]heptanylidene)methyl]phenyl]azanium Chemical compound CC1(C)C2CCC1(C)C(=O)C2=CC1=CC=C([N+](C)(C)C)C=C1 QGISLNJSJIGSLZ-UHFFFAOYSA-N 0.000 description 1
- ZNEOHLHCKGUAEB-UHFFFAOYSA-N trimethylphenylammonium Chemical compound C[N+](C)(C)C1=CC=CC=C1 ZNEOHLHCKGUAEB-UHFFFAOYSA-N 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は、赤外線反射性物質を含む化粧品組成物、及び
それらを赤外線に対し人間の皮質を保護するのに用いる
ことに関する。DETAILED DESCRIPTION OF THE INVENTION Field of the Invention The present invention relates to cosmetic compositions containing infrared reflective substances and their use in protecting the human cortex against infrared radiation.
紫外線が人間の皮質(epidermis)を日焼けさ
せるのみならず皮膚(skin)を老化させる点で重要
な意味をもつことは知られている。特に、波長280〜
320nmの紅斑を生ずるUV−B11は光発癌の主因
であることは知られている。皮膚の日焼けを起こす波長
32(1−400na+のUV−A線は、UV−Bの有
害な効果を増大することも最近示されている(J。It is known that ultraviolet rays play an important role in not only tanning the human epidermis but also aging the skin. In particular, the wavelength is 280~
It is known that UV-B11, which causes erythema at 320 nm, is the main cause of photocarcinogenesis. It has also recently been shown that UV-A radiation at wavelengths 32 (1-400 na+), which causes skin tanning, augments the harmful effects of UV-B (J.
1fillis、^、 Kligman & J、 E
pstein、 The Journalof Inv
esLigative Der+maLology、
59. No、6. p。1fillis, ^, Kligman & J, E
pstein, The Journal of Inv.
esLigative Der+maLology,
59. No, 6. p.
416(19]3)〕 。416(19]3)].
しかし、地表に到達する太陽輻射線も40%の波長的7
60〜2,500n−の少ながらず重要な輻射線、即ち
赤外線も含んでいる。However, the solar radiation that reaches the earth's surface also has a wavelength of 40%.
It also contains some important radiation, ie infrared radiation, from 60 to 2,500 n-.
従って、赤外線に人間の皮質を露出することは、太陽に
自然に曝すことと密接に関連しているのみならず、暖を
取るため本を燃やす場合と同様、毛髪を乾燥するために
美容室で用いられる赤外ランプによっても起きる。Exposure of the human cortex to infrared radiation is therefore not only closely related to natural exposure to the sun, but also in hair salons for drying hair, similar to burning books for warmth. It can also occur due to the infrared lamp used.
米国ペンシルバニア大学のロレインH,クリグマン(L
orraina Il、 Kligman)番こよって
The Journalor Arch、 Derma
Lol、 Res、 272. pp、229−238
゜(1982)に発表された最近の研究では、赤外線は
生理学的に心地よいが無要なのではなく、それ自体で上
皮質(upper dermis)にエラストシス(e
lastosis)と呼ばれる毛羽に似た微細な弾力性
lI維の密な増殖、及び癌を誘発することができる繊維
の肥大をもたらすことを示している。Lorraine H., Kligman (L.), University of Pennsylvania, USA
Orraina Il, Kligman) The Journalor Arch, Derma
Lol, Res, 272. pp, 229-238
A recent study published in (1982) found that infrared light, while physiologically pleasant, is not unnecessary, and by itself induces elastosis (elastosis) in the upper dermis.
It has been shown that this results in a dense proliferation of fine elastic II fibers resembling fluff, called fibrosis (lastosis), and hypertrophy of the fibers, which can induce cancer.
更に、赤外線は血管拡張及び皮膚温度の上昇を起こし、
L、H,クリグマンの論文では“日焼は紅斑”と定義さ
れている皮膚紅斑をもたらす。Furthermore, infrared rays cause vasodilation and increase in skin temperature,
Sunburn results in skin erythema, defined as "erythema" in the article by L.H. Kligman.
従って、赤外線を、人間の皮質に対するその有害な紅斑
を減少させるため、反射させることが有用であることが
判明している。It has therefore been found useful to reflect infrared radiation to reduce its harmful erythema on the human cortex.
成る不透明な顔料が持つ自然の輻射線を反射する性質は
知られている。そのような顔料には、金属塩及び、二酸
化チタン及び酸化亜鉛粉末の如き酸化物粉末が含まれる
。The natural radiation-reflecting properties of opaque pigments are known. Such pigments include metal salts and oxide powders such as titanium dioxide and zinc oxide powders.
しかし、人間の皮質を保護する化粧品組成物に金属塩及
び酸化物粉末からなる反射性剤を使用することは、皮膚
の上に魅力のない白色膜を形成する欠点を有する。However, the use of reflective agents consisting of metal salts and oxide powders in cosmetic compositions for protecting the human cortex has the disadvantage of forming an unattractive white film on the skin.
従って、多くの研究は、化粧品組成物に配合した時、潜
在的に害を与える赤外線を満足に反射することと、使用
者に嫌われる皮膚上に残る白色膜を生じない化粧品保護
被覆を得ることの両方を可能にする、新しい物質を発見
するために行われてきた。更に、そのような組成物は、
粘着する感触をもたず、皮膚に良く付着することの外、
良好な化学的及び光化学的安定性を示す必要がある。Therefore, much research has been devoted to obtaining cosmetic protective coatings that, when incorporated into cosmetic compositions, satisfactorily reflect potentially harmful infrared rays and do not leave a white film on the skin that is disliked by the user. Efforts have been made to discover new substances that make both possible. Furthermore, such compositions
In addition to not having a sticky feel and adhering well to the skin,
It must exhibit good chemical and photochemical stability.
本発明によれば、用いられる化粧品媒体中に分散可能な
成る物質で、少なくとも45%、好ましくは55%の赤
外線反射率(R)を有し、石油ゼリー中に2%の濃度で
分散させたものが少なくとも85%、好ましくは少な(
とも90%の可視領域の光透過率を有する成る物質が、
赤外線を反射すると共に、それを含む化粧品組成物に上
述の希望の有利な性質を与えることが驚くべきことに見
出された。特に、それらは人間の皮質上で透明性を示し
、皮膚への良好な接着、良好な化学的及び光化学的安定
性の外、赤外線によって起きる“日焼け″紅斑の減衰を
示す。According to the invention, a substance comprising a substance dispersible in the cosmetic medium used, having an infrared reflectance (R) of at least 45%, preferably 55%, dispersed in a petroleum jelly at a concentration of 2%. at least 85%, preferably less (
Both have a light transmittance of 90% in the visible region,
It has surprisingly been found that it reflects infrared radiation while imparting the desired advantageous properties mentioned above to cosmetic compositions containing it. In particular, they exhibit transparency on the human cortex, good adhesion to the skin, good chemical and photochemical stability, as well as attenuation of the "sunburn" erythema caused by infrared radiation.
従って、本発明は、赤外線から人間の皮質を保護するの
に適した化粧品組成物で、化粧品として許容出来るビヒ
クル中に、100μm以下の粒径を有する珪藻、100
μ肩以下の粒径を有する中空ガラス微小球、75μm以
下の粒径を有するオキシ塩化ビスマス、又は8μm以下
の粒径を有するジルコニウム被覆セラミック微粒子から
なる少なくとも一種類の赤外線反射性物質を入れたもの
からなり、然も、その物質は、少なくとも45%に等し
い赤外線反射率(R)を有し、石油ゼリー中に前記物質
を2%の濃度で分散させたものが少なくとも85%の可
視領域の光透過率を有する化粧品組成物を与える。一般
に好ましい粒径について、珪藻は80μm以下、中空ガ
ラス微小球は80μ膚以下、オキシ塩化ビスマスは40
μm以下、ジルコニウム被覆セラミック微粒子は8μ層
以下である。The present invention therefore provides a cosmetic composition suitable for the protection of the human cortex from infrared radiation, comprising 100 diatoms having a particle size of less than 100 μm in a cosmetically acceptable vehicle.
Contains at least one type of infrared reflective material consisting of hollow glass microspheres with a particle size of μ shoulder or less, bismuth oxychloride with a particle size of 75 μm or less, or zirconium-coated ceramic fine particles with a particle size of 8 μm or less provided that the substance has an infrared reflectance (R) equal to at least 45% and that a dispersion of said substance in petroleum jelly at a concentration of 2% reflects at least 85% of the visible range of light. Provides a cosmetic composition with transmittance. Generally preferred particle sizes are 80 μm or less for diatoms, 80 μm or less for hollow glass microspheres, and 40 μm or less for bismuth oxychloride.
The thickness of the zirconium-coated ceramic fine particles is 8μ or less.
本発明は、更に、上で規定した少なくとも一種類の赤外
線反射性物質を含む組成物を充分な量皮膚に適用するこ
とからなる、赤外線に対し人間の皮質を保護するための
方法で用いるための組成物を与える。また、本発明は、
赤外線に対し人間の皮質を保護する上で規定した少なく
とも一種類の赤外線反射性物質を含む組成物を化粧品製
品として使用することも与える。The invention further provides for use in a method for protecting the human cortex against infrared radiation, comprising applying to the skin a sufficient amount of a composition comprising at least one infrared reflective substance as defined above. Give the composition. Moreover, the present invention
It is also provided that the composition comprising at least one infrared reflective substance defined in the protection of the human cortex against infrared radiation is used as a cosmetic product.
本発明に従い、使用するのに特に適した赤外線反射性物
質には、
“クラーゼル(CLAR3EL)D I C/B″の名
前で5ocieLe Bretonne de Pro
duits Cbimiqeset Pharmace
utiqueaから販売されている5〜80μmの粒径
をもつ゛穂藻、
“ガラス微小球(Glass Hicrosphere
s) E22X”の名前で3M社から販売されている7
5μ層以下の中空ガラス微小球、
“パール(PEARL)GLO″の名前でマリンクロッ
ト(MALLI NCKRODT)社から販売されてい
る6〜15μlの平均粒径をもつオキシ塩化ビスマス、
及び
“トーレイセラム(TOFtAYCIli:RAM)”
の名前で東し社から販売されている4〜5μlの粒径を
もつジルコニウム被覆セラミック微粒子、例えば、“ト
ーレイセラムZP55G“及び“トーレイセラムzP4
000″
が含まれる。Infrared reflective materials particularly suitable for use in accordance with the present invention include those manufactured under the name "CLAR3EL DI C/B".
duits Cbimiqeset Pharmace
"Glass Hicrosphere" is a ``Glass Hicrosphere'' with a particle size of 5 to 80 μm sold by Utiquea.
s) 7 sold by 3M under the name "E22X"
Hollow glass microspheres with a layer of less than 5 μl, bismuth oxychloride with an average particle size of 6 to 15 μl, sold by MALLI NCKRODT under the name “PEARL GLO”;
and “TOFtAYCIli:RAM”
Zirconium-coated ceramic fine particles with a particle size of 4 to 5 μl sold by Toshisha under the name of
000″ is included.
赤外線反射性物質の反射率(R)が大きくなる程、それ
は効果的になる。The greater the reflectance (R) of an infrared reflective material, the more effective it is.
反射率は、反射光線の強度対入射光線の強度の比である
。この測定は、“インフラ・アリセール(1lfr@−
alyseur)″として知られている装置を用いて1
.100〜2.500nmの範囲の波長領域で行われる
。Reflectance is the ratio of the intensity of reflected light to the intensity of incident light. This measurement is based on “Infra Alisale (1lfr@-
1 using a device known as
.. It is carried out in the wavelength range of 100 to 2.500 nm.
石油ゼリー中に反射性物質を2%の濃度で分散させたも
のの可視領域での光透過率は、約10μの薄い層を用い
て400〜700nmの範囲の波長領域で積分回転体を
具えた分光計によって測定される。The light transmittance in the visible region of a reflective substance dispersed in petroleum jelly at a concentration of 2% is determined by the spectroscopy with an integrating rotor in the wavelength range of 400 to 700 nm using a thin layer of about 10μ. measured by a meter.
光透過率は、透過光線の強度対入射光線の比である。Light transmittance is the ratio of the intensity of transmitted light to the incident light.
本発明による赤外線反射性物質は、−mに化粧品組成物
中、その組成物全重量に基づき0.5〜20重凰%、例
えば、1〜10重量%、特に1〜3重1%の割合で存在
する。The infrared reflective substance according to the invention is present in the cosmetic composition in a proportion of 0.5 to 20% by weight, for example 1 to 10% by weight, especially 1 to 3% by weight, based on the total weight of the composition. exists in
本発明による化粧品組成物は、従来の技術でよく知られ
ていて本発明により用いられる赤外線反射性物質と相容
性のある紫外線遮蔽剤を含んでいてもよい、これらの紫
外線遮蔽剤は、リピド可溶性又は水溶性のUV−A、U
V−B又は広帯域遮蔽剤にすることができる。Cosmetic compositions according to the invention may also contain UV-screening agents that are well known in the art and are compatible with the infrared-reflecting substances used according to the invention; these UV-screening agents include lipid Soluble or water-soluble UV-A, U
It can be a V-B or broadband screening agent.
そのような物質は、本発明による化粧品組成物中、その
組成物の全重量に基づき0.5〜20重量%の割合で存
在するのが適切である。Suitably such substances are present in the cosmetic composition according to the invention in a proportion of 0.5 to 20% by weight, based on the total weight of the composition.
次の化合物は、本発明の組成物で用いるのに適したUV
遮蔽剤の例であるニ
ーp−アミノ安息香酸、次の如きそのエステル及び誘導
体:
エチルN、N−ジヒドロキシ10ピル−p−アミノベン
ゾエート
エチルN−エポキシ−p−アミノベンゾエートエチルp
−ジメチルアミノベンゾエートアミルp−ジメチルアミ
ノベンゾエートグリセリルp−アミノベンゾエート
ブチルp−ジメチルアミノベンゾエート2−エチルヘキ
シルp−ジメチルアミノベンゾエート
一次のサリチレート:
カリウム又はトリエタノールアミン サリチレート
アミルサリチレート
メンチルサリチレート
ホモメンチルサリチレート
2−エチルへキシルサリチレート
フェニルサリチレート
ベンジルサリチレート
p−イソプロパツールフェニルサリチレートイソデシル
サリチレート
一ホモメンチルN−アセチルアントラニレ−1・−次の
シンナメート及びケイ皮酸誘導体:ケイ皮酸カリウム
オフナルシンナメート
エチル4−イソプロピルシンナメート
エチル 2.4−ジイソプロピルシンナメートメチル
2,4−ジイソプロピルシンナメートp−メトキシケイ
皮酸及びその塩
プロピルp−メトキシシンナメート
イソプロビルp−メトキシシンナメートイソアミルp−
メトキシシンナメート
2−エチルヘキシルp−メトキシシンナメート2−工ト
キシエチルp−メトキシシンナメートシクロヘキシルp
−メトキシシンナメートエチルα−シアノ−β−フェニ
ルシンナメート2−エチルヘキシルα−シアノ−β−フ
ェニルシンナメート
一次のベンゾフェノン:
2.4−ジヒドロキシベンゾフェノン
2.2′−ジヒドロキシ−4−メトキシベンゾフェノン
2.2′−ジヒドロキシ−484′−ジメトキシベンシ
フエノン
2.2゛−ジヒドロキシ−4,4′−ジメトキシベンゾ
フェノン−5−スルホン酸及びその塩2.2’、4.4
’−テトラヒドロキシベンゾフェノン
2−ヒドロキシ−4−メトキシベンゾフェノン2−しド
ロキシ−4−メトキシ−4′−メチルベンゾフェノン
2−ヒドロキシ−4−メトキシベンゾフェノン−5−ス
ルホン酸及びその塩
4−フェニルベンゾフェノン
2−エチルヘキシル4′−フェニルベンゾフェノン−2
−カルボキシレート
2−しドロキシ−4−n−オクチルオキシベンゾフェノ
ン
4−ヒドロキシ−3−ベンゾフェノンカルボン酸及びそ
の塩
−2−フェニルベンズイミダゾール−5−スルホン酸及
びその塩
一ウロカニン酸及びその場
−エチルつロカネート
−2−フェニル−5−メチルベンズオキサゾール−2−
(2’−ヒドロキシ−5′−メチルフェニル)ベンゾト
リアゾール
−2−(2’−ヒドロキシ−5゛−t−オクチルフェニ
ル)ベンゾトリアゾール
一ナトリウム 3.4−ジメトキシフェニルグリオキシ
レート
ージベンザルアジン
ージアニソイルメタン
ー4−イソプロピルジベンゾイルメタン−4−(−ブチ
ル−4′−メトキシジベンゾイルメタン
−3−ベンジリデン−41−ショウノウ−3−(4’−
メチルベンジリデン)−,11−ショウノウ
−3−(4’−スルホベンジリデン)ショウノウ酸及び
その塩(フランス特許筒2,282,426号)−3−
(3″−スルホ−4′−メチルベンジリデン)ショウノ
ウ酸及びその塩(フランス特許筒2,236,515号
)−4−(2−オキソ−3−ボルニリデンメチル)フェ
ニルトリメチルアンモニウムメチルサルフェート(フラ
ンス特許筒2,199,911号)−メチルオイゲノー
ル
ーグアニン
ージガロイルトリオレエート
−5−(3,3−ジメチル−2−ノルボルニリデン)−
3−ペンテン−2−オン
一ベンゼンー1.4−ビス(3−メナリデン)−10−
ショウノウスルホン酸及びその塩(フランス特許筒2.
528,420号)
−N−(2−エチルヘキシル)−4−(3’−メチリデ
ンシジウノウ)ベンゼンスルホンアミド(フランス特許
筒2,529,887号)
−N−(2−エチルヘキシル)−3−[(3°−メトキ
シ−4’−n−ブトキシ)ベンジリデン】−10−ショ
ウノウスルホンアミド(フランス特許筒2,529,8
87号)−N−(2−エチルヘキシル)−3−ベンジリ
デン−10−ショウノウスルホンアミド(フランス特許
筒2.529,887号)
−20,000より小さいMWの3−[4’−(アクリ
ルアミドメチル)ベンジリデン]−J2−ショウノウの
単独重合体(フランス特許筒2,601,365号)−
2−[(2’−ヒドロキシ−5′−t−オクチル)フェ
ニル]−28−ベンゾトリアゾールとブチルビニルエー
テルとの共重合体(フランス特許筒2,601,365
号)
本発明による化粧品組成物は、一種類以上の溶媒又は脂
肪中の懸濁物又は分散物の形、クリーム、乳液の如きエ
マルジョンの形、又は軟膏、ゲル又は固体スティックの
形で与えられるのが適切であり、又はスプレー(aer
osol)として包装されていてもよく、発泡体の形で
与えられてもよい。The following compounds are suitable for use in the compositions of the present invention.
Examples of screening agents are p-aminobenzoic acid, its esters and derivatives such as: ethyl N, N-dihydroxy 10-pyl-p-aminobenzoate ethyl N-epoxy-p-aminobenzoate ethyl p
-dimethylaminobenzoate amyl p-dimethylaminobenzoate glyceryl p-aminobenzoate butyl p-dimethylaminobenzoate 2-ethylhexyl p-dimethylaminobenzoate Primary salicylates: potassium or triethanolamine salicylate amyl salicylate menthyl salicylate homo Menthyl salicylate 2-Ethylhexyl salicylate Phenyl salicylate Benzyl salicylate p-Isopropanol Phenyl salicylate Isodecyl salicylate - Homomenthyl N- Acetyl anthraniley - 1 - The following cinnamates and silicon Namic acid derivatives: Potassium cinnamate ethyl 4-isopropyl cinnamate 2,4-diisopropyl cinnamate methyl
2,4-Diisopropylcinnamate p-methoxycinnamic acid and its salts Propyl p-methoxycinnamate Isoprobyl p-methoxycinnamate Isoamyl p-
Methoxycinnamate 2-ethylhexyl p-methoxycinnamate 2-ethoxyethyl p-methoxycinnamate cyclohexyl p
-Methoxycinnamate Ethyl α-cyano-β-phenylcinnamate 2-Ethylhexyl α-cyano-β-phenylcinnamate Primary benzophenones: 2.4-dihydroxybenzophenone 2.2'-dihydroxy-4-methoxybenzophenone 2.2 '-Dihydroxy-484'-dimethoxybensiphenone 2.2'-dihydroxy-4,4'-dimethoxybenzophenone-5-sulfonic acid and its salts 2.2', 4.4
'-Tetrahydroxybenzophenone 2-hydroxy-4-methoxybenzophenone 2-droxy-4-methoxy-4'-methylbenzophenone 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid and its salts 4-phenylbenzophenone 2-ethylhexyl 4'-phenylbenzophenone-2
-carboxylate 2-droxy-4-n-octyloxybenzophenone 4-hydroxy-3-benzophenonecarboxylic acid and its salts -2-phenylbenzimidazole-5-sulfonic acid and its salts monourocanic acid and in situ-ethyl Rocanate-2-phenyl-5-methylbenzoxazole-2-
(2'-Hydroxy-5'-methylphenyl)benzotriazole-2-(2'-hydroxy-5'-t-octylphenyl)benzotriazole monosodium 3.4-dimethoxyphenylglyoxylate-dibenzalazine-diani Soilmethane-4-isopropyldibenzoylmethane-4-(-butyl-4'-methoxydibenzoylmethane-3-benzylidene-41-camphor-3-(4'-
methylbenzylidene)-,11-camphor-3-(4'-sulfobenzylidene) camphoric acid and its salts (French Patent No. 2,282,426) -3-
(3″-Sulfo-4′-methylbenzylidene) camphoric acid and its salts (French Patent No. 2,236,515) -4-(2-oxo-3-bornylidenemethyl)phenyltrimethylammonium methylsulfate (French Patent No. 2,236,515) Patent No. 2,199,911) -Methyleugenol-guanine-digalloyltrioleate-5-(3,3-dimethyl-2-norbornylidene)-
3-penten-2-one-benzene-1,4-bis(3-menalidene)-10-
Camphor sulfonic acid and its salts (French Patent Co., Ltd. 2.
528,420) -N-(2-ethylhexyl)-4-(3'-methylidenesidium)benzenesulfonamide (French Patent No. 2,529,887) -N-(2-ethylhexyl)-3- [(3°-methoxy-4'-n-butoxy)benzylidene]-10-camphorsulfonamide (French Patent No. 2,529,8
No. 87) -N-(2-ethylhexyl)-3-benzylidene-10-camphorsulfonamide (French Patent No. 2.529,887) -3-[4'-(acrylamidomethyl) with MW less than 20,000 benzylidene]-J2-homopolymer of camphor (French Patent No. 2,601,365)-
Copolymer of 2-[(2'-hydroxy-5'-t-octyl)phenyl]-28-benzotriazole and butyl vinyl ether (French Patent No. 2,601,365)
The cosmetic composition according to the invention may be presented in the form of a suspension or dispersion in one or more solvents or fats, in the form of an emulsion such as a cream, emulsion, or in the form of an ointment, gel or solid stick. is suitable, or spray (aer) is suitable.
osol) or provided in foam form.
金属イオン封鎖剤、酸化防止剤、消泡剤、油、ワックス
、ラノリン、香料、噴射剤、着色剤、ビタミン又は化粧
品で慣用的に用いられる他の成分の中に化粧品助剤を含
有させることができる。Cosmetic auxiliaries may be included in sequestrants, antioxidants, antifoams, oils, waxes, lanolin, fragrances, propellants, colorants, vitamins or other ingredients conventionally used in cosmetics. can.
組成物をスプレーとして包装する場合、アルカン、フル
オロアルカン及びクロロフルオロアルカンの如き慣用的
噴射剤が用いられる。When the composition is packaged as a spray, conventional propellants such as alkanes, fluoroalkanes and chlorofluoroalkanes are used.
本発明の化粧品組成物中に存在する主たる助剤は、水又
は1〜6個の炭素原子を有する低級−価アルコール又は
ポリオール又はそれらの混合物の如き溶媒が適切であり
、特に好ましい一価アルコール又はポリオールはエタノ
ール、イソプロパツール、プロピレングリコール、グリ
セリン及びソルビトールである。鉱物、動物、植物又は
合成の油又はワックスの如き脂肪、脂肪酸、6〜12個
の炭素原子を有する脂肪酸のトリグリセリドの如き脂肪
酸エステル、脂肪アルコール、石油ゼリーパラフィン、
ラノリン、水素化ラノリン1、アセチル化ラノリン及び
シリコーン油も適切である。The main auxiliaries present in the cosmetic compositions of the invention are suitably solvents such as water or lower-hydric alcohols or polyols having 1 to 6 carbon atoms or mixtures thereof, particularly preferably monohydric alcohols or Polyols are ethanol, isopropanol, propylene glycol, glycerin and sorbitol. fats such as mineral, animal, vegetable or synthetic oils or waxes, fatty acids, fatty acid esters such as triglycerides of fatty acids having 6 to 12 carbon atoms, fatty alcohols, petroleum jelly paraffins,
Also suitable are lanolin, hydrogenated lanolin 1, acetylated lanolin and silicone oils.
本発明の一つの態様は、赤外線反射剤の他に水の存在下
に脂肪アルコール、脂肪酸エステル、特に脂肪酸トリグ
リセリド、脂肪酸、ラノリン及びその誘導体、天然又は
合成の油又はワックス及び乳化剤を含むクリーム又は乳
液の形のエマルジョンからなる。One embodiment of the invention provides a cream or emulsion comprising, in addition to the infrared reflector, fatty alcohols, fatty acid esters, in particular fatty acid triglycerides, fatty acids, lanolin and derivatives thereof, natural or synthetic oils or waxes and emulsifiers in the presence of water. It consists of an emulsion in the form of
油中水型エマルジョンは一つの好ましい態様である。Water-in-oil emulsions are one preferred embodiment.
この種のエマルジョンは、水性相、脂肪相及び乳化用系
からなる。Emulsions of this type consist of an aqueous phase, a fatty phase and an emulsifying system.
この種のエマルジョン中乳化系の濃度は、エマルジョン
の全重量を基にして4〜35%であり、脂肪相はエマル
ジョンの全重量を基にして20〜70%の割合で存在す
る。乳化用剤はこの種のエマルジョンに慣用的に用いら
れている乳化剤である。適当な例には、次のものが含ま
れる:
ソルビタンの脂肪酸(CI2〜C4)エステル;ヒドロ
キシステアリン酸と脂肪アルコール(0,2〜C3゜)
のエステル;
一脂肪酸(C1,〜C8,)とグリセロール又はポリグ
リセロールのモノ及びジエステル;
酸化エチレンとプロピレングリコールとの縮合物;
一オキシプロピレン化/オキシエチレン化脂肪アルコー
ル(CI2〜C2゜);
ステロールの如き多環アルコールニ
ーラノリンの如き高分子量脂肪族アルコール;−オキシ
プロピレン化/ポリグリセロール化アルコールとイソジ
チアリン酸マグネシウムとの混合物;
一ポリオキシエチレン化又はポリオキシプロピレン化脂
肪アルコールのコハク酸エステル;及び−マグネシウム
ラル−ト、カルシウムラル−ト、リチウムラル−ト、亜
鉛ラル−ト又はアルミニウムラル−ト及びラノリンアル
コール又は水素化ラノリンの混合物。The concentration of the emulsifying system in emulsions of this type is 4-35%, based on the total weight of the emulsion, and the fatty phase is present in a proportion of 20-70%, based on the total weight of the emulsion. The emulsifying agent is the emulsifying agent conventionally used in emulsions of this type. Suitable examples include: fatty acid (CI2-C4) esters of sorbitan; hydroxystearic acid and fatty alcohols (0,2-C3°)
esters of monofatty acids (C1, to C8,) and glycerol or polyglycerols; condensates of ethylene oxide and propylene glycol; monooxypropylenated/oxyethylenated fatty alcohols (CI2 to C2°); sterols polycyclic alcohols such as nylanolin; mixtures of oxypropylenated/polyglycerolated alcohols with magnesium isodithiaphosphate; succinic acid esters of monopolyoxyethylenated or polyoxypropylenated fatty alcohols; and - mixtures of magnesium ralt, calcium ralt, lithium ralt, zinc ralt or aluminum ralt and lanolin alcohol or hydrogenated lanolin.
エマルジョンの脂肪相を形成する脂肪生成物の例には次
のものが含まれるニ
ーパラフィン油、パルセリン(purcellin)油
、ペルヒドロスクワレン及び微結晶質ワックスの油中の
溶液、
一スィートアーモンド油、アボカド油、カロフィラム油
、ラノリン及びその誘導体、ヒマシ油、カバリン油、豚
油、ごま油、オリーブ油、ホホバ油、シx −(5he
a)油、ホプロステタス(Iioplostethus
)油の如き動物又は植物オイル、
一大気圧での初期蒸留点が約250℃で、最終点が41
0℃位である、液体パラフィンの如き鉱物油、イソプロ
ピル、ブチル又はセチルミリステー1・の如きアルキル
ミリステート、ヘキサデシルステアレート、エチル又は
イソプロピルパルミテート、オクタン酸及びデカノン酸
のトリグリセリド及びセチル リシルエートの如き飽和
又は不飽和脂肪酸エステル、
脂肪相は適切には、ジメチルボリシロキ酸、メチルフェ
ニルボリシロキ酸及びシリコーン/グリコール共重合体
、脂肪酸及び脂肪アルコールの如き他の油に可溶性のシ
リコーンオイルも含んでいる。Examples of fatty products forming the fatty phase of the emulsion include: paraffin oil, purcellin oil, solutions of perhydrosqualene and microcrystalline wax in oil, sweet almond oil, avocado oil, calophyllum oil, lanolin and its derivatives, castor oil, kavaline oil, pork oil, sesame oil, olive oil, jojoba oil, x-(5he
a) Oil, Iioplostethus
) animal or vegetable oils, such as oils, whose initial distillation point at one atmospheric pressure is approximately 250°C and whose final point is 41°C.
Mineral oil such as liquid paraffin, alkyl myristates such as isopropyl, butyl or cetyl myristate, hexadecyl stearate, ethyl or isopropyl palmitate, triglycerides of octanoic and decanonic acids and cetyl lysyl ate, at about 0°C. saturated or unsaturated fatty acid esters, such as saturated or unsaturated fatty acid esters, the fatty phase suitably also contains silicone oils soluble in other oils, such as dimethylborisiloxic acid, methylphenylborosiloxic acid and silicone/glycol copolymers, fatty acids and fatty alcohols. There is.
油の保持を促進するため、カルナバ蝋、カンデリラ蝋、
蜜蝋、微結晶質ワックス、オシケライト及びCa、Mg
及びA1のオレイン酸塩、ミリスチン酸塩、リノール酸
塩及びステアリン酸塩の如きワックスを用いることもで
きる。Carnauba wax, candelilla wax,
Beeswax, microcrystalline wax, osikelite and Ca, Mg
Waxes such as oleate, myristate, linoleate and stearate of A1 and A1 can also be used.
油中水型のエマルジョンは日焼は止めステックの形で与
えられてもよい、この場合には、エマルシリン中の水性
相の濃度はエマルジョンの全重量に基づき一般に5〜7
0重量%である。Water-in-oil emulsions may also be provided in the form of sunscreen sticks, in which case the concentration of the aqueous phase in the emulsion is generally between 5 and 7, based on the total weight of the emulsion.
It is 0% by weight.
−mに、これらの油中水型エマルジョンは次のようにし
て製造される。製造タンク中に脂肪相と乳化剤を導入す
る。混合物をフO〜75℃の温度に加熱する0次に油溶
性成分を添加し、その後で予め同じ温度にしておいた水
で、その中伸水溶性成分を前以て溶かして置いた水を撹
拌しながら添加する。希望の滑らかさをもつエマルジョ
ンが得られるまで撹拌し、次に任意にゆっくり攪拌しな
がら、室温へ冷却する。-m, these water-in-oil emulsions are manufactured as follows. Introducing the fat phase and emulsifier into the production tank. Heat the mixture to a temperature of ~75°C. Next, add the oil-soluble ingredients, and then add the water-soluble ingredients in water that has been previously brought to the same temperature. Add while stirring. Stir until an emulsion with the desired smoothness is obtained, then cool to room temperature, optionally with slow stirring.
脂肪ゲルは、油又はワックス及びシリカの如き濃化剤を
含む、油性アルコール又は水性アルコール ゲルは、夫
々油又は水の存在下で、エタノール、プロピレングリコ
ール又はグリセリンの如き一種類以上のアルコール又は
ポリオール、シリカ、セルロース誘導体、ポリアクリル
酸誘導体、グアーガム、力ロブガム及びキサンタンガム
の如き濃化剤を含む。Fatty gels are oil-based or hydroalcoholic, containing thickening agents such as oils or waxes and silica; gels are made of one or more alcohols or polyols, such as ethanol, propylene glycol or glycerin, in the presence of oil or water, respectively; Contains thickening agents such as silica, cellulose derivatives, polyacrylic acid derivatives, guar gum, lilac gum, and xanthan gum.
固体ステックは天然又は合成のワックス及び油、脂肪ア
ルコール、脂肪酸エステル及びラノリンの如き脂肪を含
んでいる。Solid sticks contain natural or synthetic waxes and oils, fatty alcohols, fatty acid esters, and fats such as lanolin.
次の実施例は、更に本発明を例示するものである。The following examples further illustrate the invention.
実施PA1
人間の皮質を保護する透明クリームを次の組成の油中水
型エマルジョンの形で調製した:2−オクチルー1−ド
デカノール 10gステアリン酸マグネシウ
ム 4 #蜜蝋
5g水素化ラノリン
1fIラノリン
4g101社から“アーラセル(ARLACEL)83
”の名で販売されているソルビタンセスキオレエー)
4.5゜グリセロールモノ
−及びジ−ステアレートとステアリン酸カリウムの混合
物 1゜液体パラフィン
27#ソプレツプ(SOBREP)社から“クラーゼ
ル(CLAR3EL)DIC/B”と言う名で販売され
ている珪藻 2gサットン・ラプス(
SUTTON Labs)社から“ジャーモール(G
ERMALL)115”の名で販売されているイミダゾ
リジニル尿素誘導体 0.2
j香料 、3水
qslooi
lこのクリームは、エマルジョンを製造する慣用的方法
に従い、脂肪及び乳化剤中に赤外線反射剤を分散させ、
この脂肪相を約70〜75℃に加熱し、強く撹拌しなが
ら水を添加し、同じ<70〜75℃に加熱し、撹拌を1
0〜15分継続し、次に混合物を穏やかに攪拌しながら
冷却し、約40’Cで香料及び防腐剤を添加した。Implementation PA1 A transparent cream for protecting the human cortex was prepared in the form of a water-in-oil emulsion with the following composition: 2-octyl-1-dodecanol 10 g Magnesium stearate 4 #beeswax
5g hydrogenated lanolin
1fI lanolin
“ARLACEL 83” from 4g101 company
Sorbitan sesquioleae (sold under the name ``Sorbitan Sesquioleae'')
4.5° Mixture of glycerol mono- and di-stearate and potassium stearate 1° Liquid paraffin
27# Diatom 2g Sutton Lapus (sold by SOBREP under the name “CLAR3EL DIC/B”)
“Jermall (G)” from SUTTON Labs
Imidazolidinyl urea derivative sold under the name "ERMALL) 115" 0.2
J fragrance, 3 water
qsloooi
This cream is prepared by dispersing infrared reflectors in fat and emulsifiers according to conventional methods of making emulsions.
Heat this fatty phase to about 70-75 °C and add water with strong stirring, heat to the same <70-75 °C and reduce stirring to 1
It lasted 0-15 minutes, then the mixture was cooled with gentle stirring and the flavor and preservative were added at about 40'C.
実施例2
実施例1の如く、人間の皮質を保護する透明クリームを
、次の組成を有する油中水型エマルジョンの形で調製し
た。Example 2 As in Example 1, a clear cream for protecting the human cortex was prepared in the form of a water-in-oil emulsion with the following composition:
2−オクチル−1−ドデカノール 10
。2-octyl-1-dodecanol 10
.
ステアリン酸マグネシウム 4g蜜蝋
5 。Magnesium stearate 4g beeswax
5.
水素化ラノリン 1yラノリ
ン 41ICI社から
“アーラセル83“の名で販売されているンルビタンセ
スキオレエート 4.5゜グリセロールモノ−及びジ
−ステアレートとステアリン酸カリウムの混合物
1g液体パラフィン 27 9
3M社から“ガラス微小球E22X″と言う名で販売さ
れている中空ガラス微小球 2gサットン・ラプス社か
ら“ジャーモール115“の名で販売されているイミダ
ゾリシェル尿素誘導体 0.2゜香
料 、S水
qs 100
g実施IM3
人間の皮質を保護する透明クリームを、次の組成の油中
水型エマルジョンの形で調製した:2−オクチルー1−
ドデカノール 10 fステアリン酸マグ
ネシウム 4g蜜蝋
5g水素化ラノリン
1gラハン 4
#IC1社から“アーラセル83“の名で販売されて
いるソルビタンセスキオレエート 4.5tグリセロー
ルモノ−及びジ−ステアレートとステアリン酸カリウム
の混合物 1g液体パラフィン
27g東し社から“トーレイセラムZP550”
と言う名で販売されているジルコニウム粉末で被覆され
たセラミック微粒子 23サツトン・ラプス社か
ら“ジャーモール115“の名で販売されているイミダ
ゾリジニル尿素誘導体 0.
2゜香料 Qs水
qs 1
00 g実施例4
人間の皮質を保護する透明クリームを、次の組成の油中
水型エマルジョンの形で調製した:2−オクチルー1−
ドデカノール 10tステアリン酸マグネシ
ウム 4I密蝋
5g水素化ラノリン
1gラハン 4 。Hydrogenated lanolin 1y lanolin 41 Nrubitan sesquioleate sold by ICI under the name "Aracel 83" 4.5° Mixture of glycerol mono- and di-stearate and potassium stearate
1g liquid paraffin 27 9
Hollow glass microspheres sold by 3M Company under the name "Glass Microspheres E22X" 2g Imidazolishell urea derivative sold by Sutton Lapus Company under the name "Germol 115" 0.2° fragrance, S water
qs 100
g Implementation IM3 A transparent cream for protecting the human cortex was prepared in the form of a water-in-oil emulsion with the following composition: 2-octyl-1-
Dodecanol 10 f Magnesium stearate 4 g Beeswax
5g hydrogenated lanolin
1g lahan 4
#Sorbitan sesquioleate sold under the name "Aracel 83" by IC1 4.5t Mixture of glycerol mono- and di-stearate and potassium stearate 1g liquid paraffin
27g Toray Serum ZP550 from Toshisha
Ceramic fine particles coated with zirconium powder sold under the name 23. Imidazolidinyl urea derivative sold under the name "Germol 115" by Sutton Lapus Co. 0.
2゜Fragrance Qs water
qs 1
00 g Example 4 A transparent cream for protecting the human cortex was prepared in the form of a water-in-oil emulsion with the following composition: 2-octyl-1-
Dodecanol 10T Magnesium Stearate 4I Beeswax
5g hydrogenated lanolin
1g lahan 4.
IC1社から“アーラセル83“の名で販売されている
ソルビタンセスキオレエート 4.5gグリセロール
モノ−及びジ−ステアレートとステアリン酸カリウムの
混合物 1g液体パラフィン
27 gマリンクロット社から“パールGLO”
の名で販売されているオキシ塩化ビスマス 2gサット
ン・ラプス社から“ジャーモール115”の名で販売さ
れているイミダゾリシェル尿素誘導体
0.2゜香料 qs水
qs
100 y実施例5
人間の皮質を保護する透明クリームを、次の組成を有す
る油中水型エマルジョンの形で調製した:
ヘンケル(HENKEL)社から゛°ジノワックス(S
I NN0WAX)AO’の名で販売されている七チ
ル/ステアリルアル
コールと33モルの酸化エチレン交オキシエチレン化さ
れたセチル/ステアリ
ルアルコールとの混合物 フジモノ−及び
ジ−ステアレート 2g七チルアルコー
ル 1.52シリコーンオイル
1.5g液体パラフィン
15 gフランス特許第2,19
9,971号明細書の実施例1に従い製造された4−(
2−オキソ−3−ボルニリデンメチル)フェニルトリメ
チルアンモニウムメチルサルフェート2g乳酸ナトリウ
ム 1g東し社から“トーレ
イセラムZ P 55G”と言う名で販売されているジ
ルコニウム粉
末で被覆されたセラミック微粒子 2gグリセリン
20g防腐剤、香料
qs水
qs 100 g“トーレイセラ
ムZP550“は乳化剤を含む脂肪相中に分散させた。Sorbitan sesquioleate sold under the name "Aracel 83" by IC1 4.5 g mixture of glycerol mono- and di-stearate and potassium stearate 1 g liquid paraffin
27 g “Pearl GLO” from Mallinckrodt
Bismuth oxychloride sold under the name 2g imidazolyshell urea derivative sold under the name "Jermol 115" by Sutton Lapus
0.2゜Fragrance qs Water qs
100y Example 5 A transparent cream for protecting the human cortex was prepared in the form of a water-in-oil emulsion with the following composition:
Mixture of heptyl/stearyl alcohol sold under the name INN0WAX)AO' and 33 moles of oxidized ethylene cross-oxyethylenated cetyl/stearyl alcohol Fuji mono- and di-stearate 2g heptyl alcohol 1.52 silicone oil
1.5g liquid paraffin
15g French Patent No. 2,19
No. 9,971, Example 1 of 4-(
2-oxo-3-bornylidenemethyl)phenyltrimethylammonium methyl sulfate 2g Sodium lactate 1g Ceramic fine particles coated with zirconium powder sold by Toshisha under the name "Toray Ceram Z P 55G" 2g Glycerin 20g Preservative agents, fragrances
qs water
qs 100 g "Torei Serum ZP550" was dispersed in the fatty phase containing emulsifier.
水、グリセリン、乳酸ナトリウム及び4−(2−オキソ
−3−ボルニリデンメチル)フェニルトリメチルアンモ
ニウムメチルサルフエ−1・を含む水性相を70〜75
℃に加熱した。The aqueous phase containing water, glycerin, sodium lactate and 4-(2-oxo-3-bornylidenemethyl)phenyltrimethylammonium methylsulfate-1.
heated to ℃.
予め70〜75℃に加熱して置いた脂肪相を強く攪拌し
ながら水性相に添加し、次に混合物を穏やかに撹拌しな
がら冷却するままにし、約40℃で香料と防腐剤を添加
した。The fat phase, previously heated to 70-75°C, was added to the aqueous phase with vigorous stirring, then the mixture was left to cool with gentle stirring, and at about 40°C the flavor and preservative were added.
実施例6
次の組成を有する皮膚上で透明なゲルを調製した;
ソブレップ社から“クラ−セルD I C/B”と言う
名で販売されている珪藻 2g2−ヒドロキシ−
4−メトキシベンゾフェノン−5−スルホン酸(B A
S F
UV I NUL MS40) 0
.5gグツドリッチ社か°ら“カルボボール
(CA RB OP OL )940″の名で販売され
ているM W4,000,000の架橋されたポリアク
リル酸 0.3gプロピレ
ングリコール 3G 。Example 6 A transparent gel on the skin was prepared with the following composition: Diatom 2g 2-hydroxy- sold under the name "Clasel DI C/B" by Sobrep.
4-Methoxybenzophenone-5-sulfonic acid (BA
S F UV I NUL MS40) 0
.. 5 g crosslinked polyacrylic acid with a MW of 4,000,000, sold under the name "CARBOPOL 940" by Gutdrich 0.3 g propylene glycol 3G.
トリエタノールアミン 0.911金
属イオン封鎖剤、防腐剤、香料 qs水
qsloo#実施例
7
透明クリームを、次の組成を有する油中水型エマルシヨ
ンの形で調製した:
ヘンケル社から“ジノワックスAO“の名で販売されて
いるセチル/ステアリル
アルコールと33モルの酸化エチレンでオキシエチレン
化された七チル/ステTriethanolamine 0.911 Sequestering agent, preservative, fragrance qs water
qsloo #Example 7 A clear cream was prepared in the form of a water-in-oil emulsion with the following composition: Cetyl/stearyl alcohol sold under the name "Zinowax AO" by Henkel and 33 moles of ethylene oxide. Oxyethylated heptyl/ste
Claims (18)
m以下の粒径を有する珪藻、100μm以下の粒径を有
する中空ガラス微小球、75μm以下の粒径を有するオ
キシ塩化ビスマス、又は8μm以下の粒径を有するジル
コニウム被覆セラミック微粒子からなる少なくとも一種
類の赤外線反射性物質を入れたものからなり、然も、そ
の物質は少なくとも45%に等しい赤外線反射率(R)
を有し、石油ゼリー中に前記物質を2%の濃度で分散さ
せたものが少なくとも85%の可視領域の光透過率を有
する、赤外線に対し人間の皮質を保護するのに適した組
成物。(1) 100μ in a cosmetically acceptable vehicle.
at least one type consisting of diatoms having a particle size of not more than m, hollow glass microspheres having a particle size of not more than 100 μm, bismuth oxychloride having a particle size of not more than 75 μm, or zirconium-coated ceramic fine particles having a particle size of not more than 8 μm. containing an infrared reflective material, provided that the material has an infrared reflectance (R) equal to at least 45%.
A composition suitable for protecting the human cortex against infrared radiation, having a 2% concentration of said substance dispersed in petroleum jelly and having a light transmission in the visible range of at least 85%.
載の組成物。(2) The composition according to claim 1, wherein the diatom has a particle size of 80 μm or less.
請求項1又は2に記載の組成物。(3) The particle size of the hollow glass microspheres is 80 μm or less,
The composition according to claim 1 or 2.
、請求項1〜3のいずれか1項に記載の組成物。(4) The composition according to any one of claims 1 to 3, wherein the particle size of bismuth oxychloride is 40 μm or less.
射率(R)を有し、石油ゼリー中2%の濃度の分散物は
少なくとも90%の可視領域の光透過率を有する、請求
項1〜4のいずれか1項に記載の組成物。(5) The infrared reflective material has an infrared reflectance (R) of at least 55% and the dispersion at a concentration of 2% in petroleum jelly has a light transmittance in the visible range of at least 90%. 4. The composition according to any one of 4.
、75μm以下の粒径の有する中空ガラス微小球、6〜
15μmの平均粒径のオキシ塩化ビスマス、又は4〜5
μmの粒径を有するジルコニウム被覆セラミック微粒子
からなる、請求項1〜5のいずれか1項に記載の組成物
。(6) Infrared reflective substances include diatoms with a particle size of 5 to 80 μm, hollow glass microspheres with a particle size of 75 μm or less, 6 to
Bismuth oxychloride with an average particle size of 15 μm, or 4-5
Composition according to any one of claims 1 to 5, consisting of zirconium-coated ceramic microparticles having a particle size of .mu.m.
外線反射性物質を含む、請求項1〜6のいずれか1項に
記載の組成物。(7) The composition according to any one of claims 1 to 6, comprising an infrared reflective substance in an amount of 0.5 to 20% based on the total weight of the composition.
外線反射性物質を含む、請求項7に記載の組成物。8. The composition of claim 7, comprising an infrared reflective material in an amount of 1 to 10% by weight, based on the total weight of the composition.
線反射性物質を含む請求項8に記載の組成物。9. The composition of claim 8, comprising an infrared reflective material in an amount of 1 to 3% by weight, based on the total weight of the composition.
らなる紫外線遮蔽剤、又は赤外線反射性物質と相容性の
ある広帯域遮蔽剤を少なくとも一種類含む請求項1〜9
のいずれか1項に記載の組成物。(10) Claims 1 to 9 containing at least one type of ultraviolet screening agent consisting of lipid-soluble or water-soluble UV-A or UV-B, or a broadband screening agent compatible with an infrared reflective substance.
The composition according to any one of the above.
紫外線遮蔽剤を含む、請求項10に記載の組成物。(11) The composition according to claim 10, comprising 0.5 to 20% by weight of a UV screening agent, based on the total weight of the composition.
エステル又は誘導体、サリチレート、シンナメート、又
はケイ皮酸誘導体、ベンゾフェノン、2−フェニルベン
ズイミダゾール−5−スルホン酸又はその塩、ウロカニ
ン酸又はその塩、エチルウロカネート、2−フェニル−
5−メチルベンズオキサゾール、2−(2′−ヒドロキ
シ−5′−メチルフェニル)ベンゾトリアゾール、2−
(2′−ヒドロキシ−5′−t−オクチルフェニル)ベ
ンゾトリアゾール、ナトリウム3,4−ジメトキシフェ
ニル−グリオキシレート、ジベンザルアジン、ジアニソ
イルメタン、4−イソプロピル−ジベンゾイルメタン、
4−t−ブチル−4′−メトキシジベンゾイル−メタン
、3−ベンジリデン−dl−ショウノウ及びその誘導体
、メチルオイゲノール、グアニン、ジガロイルトリオレ
エート、5−(3,3−ジメチル−2−ノルボルニリデ
ン)−3−ペンテン−2−オン、20,000以下のM
Wの3−[3′−(アクリルアミドメチル)ベンジリデ
ン]−dl−ショウノウの単独重合体、又は2−[(2
′−ヒドロキシ−5′−t−オクチル)フェニル]−2
H−ベンゾトリアゾールとブチルビニルエーテルとの共
重合体である、請求項10又は11に記載の組成物。(12) The ultraviolet shielding agent is p-aminobenzoic acid or its ester or derivative, salicylate, cinnamate, or cinnamic acid derivative, benzophenone, 2-phenylbenzimidazole-5-sulfonic acid or its salt, urocanic acid or its salt. , ethyl urocanate, 2-phenyl-
5-methylbenzoxazole, 2-(2'-hydroxy-5'-methylphenyl)benzotriazole, 2-
(2'-hydroxy-5'-t-octylphenyl)benzotriazole, sodium 3,4-dimethoxyphenyl-glyoxylate, dibenzalazine, dianisoylmethane, 4-isopropyl-dibenzoylmethane,
4-tert-butyl-4'-methoxydibenzoyl-methane, 3-benzylidene-dl-camphor and its derivatives, methyleugenol, guanine, digalloyltrioleate, 5-(3,3-dimethyl-2-norbornylidene)- 3-penten-2-one, M up to 20,000
Homopolymer of 3-[3'-(acrylamidomethyl)benzylidene]-dl-camphor of W, or 2-[(2
'-Hydroxy-5'-t-octyl)phenyl]-2
The composition according to claim 10 or 11, which is a copolymer of H-benzotriazole and butyl vinyl ether.
ルジョン、クリーム、乳液、又は軟膏、ゲル又は固体ス
ティックの形をしているか、又はスプレーとして包装さ
れている、請求項1〜12のいずれか1項に記載の組成
物。(13) In the form of a suspension or dispersion in a solvent or fat, in the form of an emulsion, cream, emulsion, or ointment, gel or solid stick, or packaged as a spray. The composition according to any one of the above.
性剤、防腐剤、金属イオン封鎖剤、酸化防止剤、消泡剤
、油、ワックス、ラノリン又はその誘導体、香料、噴射
剤、着色剤又はビタミンである、請求項1〜13のいず
れか1項に記載の組成物。(14) Thickeners, cortico softeners, cortical humectants, surfactants, preservatives, sequestering agents, antioxidants, antifoaming agents, oils, waxes, lanolin or derivatives thereof, fragrances, propellants, colorants, or 14. A composition according to any one of claims 1 to 13, which is a vitamin.
ル、脂肪酸、ラノリン又はその誘導体、天然又は合成の
油又はワックス又は乳化剤の少なくとも一種類を含む油
中水型エマルジョンの形をしている、請求項1〜14の
いずれか1項に記載の組成物。(15) in the form of a water-in-oil emulsion comprising, in the presence of water, at least one of fatty alcohols, fatty acid esters, fatty acids, lanolin or derivatives thereof, natural or synthetic oils or waxes, or emulsifiers; Item 15. The composition according to any one of Items 1 to 14.
施例1〜7のいずれかに記載したものと実質的に同じ組
成物。(16) A composition as described in any one of claims 1 to 15 and substantially the same as that described in any of Examples 1 to 7.
の、赤外線に対し人間の皮質を保護する化粧品製品とし
ての使用。(17) Use of the composition according to any one of claims 1 to 16 as a cosmetic product for protecting the human cortex against infrared radiation.
成物を皮膚に適用することからなる方法で使用するため
の請求項1〜16のいずれか1項に記載の組成物。(18) A composition according to any one of claims 1 to 16 for use in a method consisting of applying the composition to the skin for protecting the human cortex against infrared radiation.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63332710A JPH02184618A (en) | 1988-12-29 | 1988-12-29 | Ir reflective transparent cosmetic composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63332710A JPH02184618A (en) | 1988-12-29 | 1988-12-29 | Ir reflective transparent cosmetic composition |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH02184618A true JPH02184618A (en) | 1990-07-19 |
Family
ID=18257999
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP63332710A Pending JPH02184618A (en) | 1988-12-29 | 1988-12-29 | Ir reflective transparent cosmetic composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH02184618A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06329524A (en) * | 1993-05-25 | 1994-11-29 | Sunstar Inc | Cosmetic compounded with bismuth compound |
JP2005162695A (en) * | 2003-12-04 | 2005-06-23 | Lion Corp | Infrared ray-shielding substance-containing cosmetic |
JP2007533627A (en) * | 2003-10-09 | 2007-11-22 | ユニリーバー・ナームローゼ・ベンノートシヤープ | Cosmetic composition for giving skin shine |
US7794740B2 (en) * | 2002-11-15 | 2010-09-14 | Color Access, Inc | Transparent concealing cosmetic compositions |
JP2012193380A (en) * | 1999-09-01 | 2012-10-11 | Merck Patent Gmbh | Pigment mixture containing biocl pigment |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4867442A (en) * | 1971-12-15 | 1973-09-14 | ||
JPS5212934A (en) * | 1975-07-16 | 1977-01-31 | Oreal | Nonnlipidic densified cosmetic stick especially suitable to eyelid makeup |
JPS5278927A (en) * | 1975-12-22 | 1977-07-02 | Merck Patent Gmbh | Pigments containing carbon black and method of their preparation |
JPS60149517A (en) * | 1984-01-13 | 1985-08-07 | Kanebo Ltd | Anti-sunburn composition |
JPS62149613A (en) * | 1985-12-24 | 1987-07-03 | Max Fuakutaa Kk | Cosmetic containing infrared ray shielding substance |
JPS62222108A (en) * | 1986-03-25 | 1987-09-30 | Hitachi Ltd | Image processing method in robot system |
JPS6327421A (en) * | 1986-07-17 | 1988-02-05 | Pola Chem Ind Inc | Cosmetic |
JPS6372620A (en) * | 1986-09-12 | 1988-04-02 | Sumitomo Chem Co Ltd | Cosmetic |
JPS63139120A (en) * | 1986-09-15 | 1988-06-10 | ユニバーシティ、オブ、マイアミ | Infrared ray reflecting composition for local application for skin |
-
1988
- 1988-12-29 JP JP63332710A patent/JPH02184618A/en active Pending
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4867442A (en) * | 1971-12-15 | 1973-09-14 | ||
JPS5212934A (en) * | 1975-07-16 | 1977-01-31 | Oreal | Nonnlipidic densified cosmetic stick especially suitable to eyelid makeup |
JPS5278927A (en) * | 1975-12-22 | 1977-07-02 | Merck Patent Gmbh | Pigments containing carbon black and method of their preparation |
JPS60149517A (en) * | 1984-01-13 | 1985-08-07 | Kanebo Ltd | Anti-sunburn composition |
JPS62149613A (en) * | 1985-12-24 | 1987-07-03 | Max Fuakutaa Kk | Cosmetic containing infrared ray shielding substance |
JPS62222108A (en) * | 1986-03-25 | 1987-09-30 | Hitachi Ltd | Image processing method in robot system |
JPS6327421A (en) * | 1986-07-17 | 1988-02-05 | Pola Chem Ind Inc | Cosmetic |
JPS6372620A (en) * | 1986-09-12 | 1988-04-02 | Sumitomo Chem Co Ltd | Cosmetic |
JPS63139120A (en) * | 1986-09-15 | 1988-06-10 | ユニバーシティ、オブ、マイアミ | Infrared ray reflecting composition for local application for skin |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06329524A (en) * | 1993-05-25 | 1994-11-29 | Sunstar Inc | Cosmetic compounded with bismuth compound |
JP2012193380A (en) * | 1999-09-01 | 2012-10-11 | Merck Patent Gmbh | Pigment mixture containing biocl pigment |
US7794740B2 (en) * | 2002-11-15 | 2010-09-14 | Color Access, Inc | Transparent concealing cosmetic compositions |
JP2007533627A (en) * | 2003-10-09 | 2007-11-22 | ユニリーバー・ナームローゼ・ベンノートシヤープ | Cosmetic composition for giving skin shine |
JP2005162695A (en) * | 2003-12-04 | 2005-06-23 | Lion Corp | Infrared ray-shielding substance-containing cosmetic |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5000937A (en) | Transparent cosmetic composition that reflects infrared radiation and its use for protecting the human epidermis against infrared radiation | |
JPS63303918A (en) | Transparent antiperspirant stick composition | |
JPH05170635A (en) | Cosmetic composition for filtered light | |
EP0452202B1 (en) | Aqueous cosmetic or dermo-pharmaceutical composition containing in suspension hydrated spheroids of hydrophilic lipidic substance | |
JPH04288010A (en) | Cosmetic | |
JPH07304644A (en) | Anti-sunburn composition | |
KR100350254B1 (en) | Cosmetic compositions comprising a silicon derivative containing a benzotriazole function and a benzoic triacid triester, and uses thereof | |
US5427771A (en) | Transparent cosmetic composition that reflects infrared radiation based on titanium dioxide flakes and its use for protecting the human epidermis against infrared radiation | |
US4793990A (en) | Use of coffee bean oil as a sun filter | |
KR100233704B1 (en) | Cosmetic compositions for skin and/or hair sun photoprotection based on a synergistic admixture of filters and use | |
EP0685224A1 (en) | Cosmetic sunscreening compositions containing a synergic mixture of filters and nanopigments and uses | |
JPH04504116A (en) | sunscreen composition | |
JPH02142719A (en) | Light-filterable cosmetic composition with light-stability | |
KR20210137124A (en) | Sunscreen Composition Containing Porous Metal Oxide Spheres | |
JP2845775B2 (en) | Photoprotective cosmetic compositions based on synergistic mixtures of screening agents and methods of use | |
JPH02184618A (en) | Ir reflective transparent cosmetic composition | |
JPH05238924A (en) | Anti-suntan cosmetic | |
PL185546B1 (en) | Cosmetic compositions exhibiting photoprotective properties and containing nanopigments, tio2 and an acylamino acid | |
KR20170061898A (en) | Oil in Water Emulsion Sunscreen Cosmetic Composition | |
JP2002265342A (en) | Ultraviolet protecting cosmetic | |
RU2242216C1 (en) | Lifting-cream for dry and sensitive skin | |
EP0862410B1 (en) | Cosmetic compositions | |
JPS62139B2 (en) | ||
US20230310290A1 (en) | Sunscreen or daily care composition comprising micronized tris-biphenyl triazine | |
JP2023539676A (en) | Sunscreen or daily care compositions containing micronized methylenebis-benzotriazolyltetramethylbutylphenol |